UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 356

Sortiert nach

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

Neuro-oncology (Charlottesville, Va.), 2019-02, Vol.21 (3), p.296-305

2019

Volltextzugriff (PDF)

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Journal of clinical oncology, 2018-02, Vol.36 (5), p.454-462

2018

Volltextzugriff (PDF)

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Neuro-oncology (Charlottesville, Va.), 2021-07, Vol.23 (7), p.1056-1071

2021

Volltextzugriff (PDF)

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

Clinical cancer research, 2022-03, Vol.28 (5), p.972-983

2022

Volltextzugriff (PDF)

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Molecular cancer research, 2021-02, Vol.19 (2), p.249-260

2021

Volltextzugriff (PDF)

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α

Pharmaceutics, 2022-07, Vol.14 (7), p.1414

2022

Volltextzugriff (PDF)

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

CA: a cancer journal for clinicians, 2016-03, Vol.66 (2), p.152-171

2016

Volltextzugriff (PDF)

CNS prophylaxis for diffuse large B-cell lymphoma

The lancet oncology, 2022-09, Vol.23 (9), p.e416-e426

2022

Volltextzugriff (PDF)

Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)

The oncologist (Dayton, Ohio), 2014-03, Vol.19 (3), p.291-298

2014

Volltextzugriff (PDF)

A Reappraisal of the Diagnostic and Therapeutic Management of Uncommon Histologies of Primary Ocular Adnexal Lymphoma

The oncologist (Dayton, Ohio), 2013-07, Vol.18 (7), p.876-884

2013

Volltextzugriff (PDF)

Primary central nervous system lymphoma – Biological aspects and controversies in management

European journal of cancer (1990), 2007-05, Vol.43 (7), p.1141-1152

2007

Volltextzugriff (PDF)

Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study

International journal of cancer, 2008-09, Vol.123 (5), p.1089-1093

2008

Volltextzugriff (PDF)

Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Journal of clinical oncology, 2012-08, Vol.30 (24), p.2988-2994

2012

Volltextzugriff (PDF)

Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial

JNCI : Journal of the National Cancer Institute, 2006-10, Vol.98 (19), p.1375-1382

2006

Volltextzugriff (PDF)

Primary and secondary bone lymphomas

Cancer treatment reviews, 2015-03, Vol.41 (3), p.235-246

2015

Volltextzugriff (PDF)

Breaching the Blood–Brain Tumor Barrier for Tumor Therapy

Cancers, 2021-05, Vol.13 (10), p.2391

2021

Volltextzugriff (PDF)

NGR-TNF Engineering with an N‑Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity

Molecular pharmaceutics, 2020-10, Vol.17 (10), p.3813-3824

2020

Volltextzugriff (PDF)

Primary central nervous system lymphoma

Nature reviews. Disease primers, 2023-06, Vol.9 (1), p.29-29, Article 29

2023

Volltextzugriff (PDF)

Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type

Seminars in cancer biology, 2014-02, Vol.24, p.33-42

2014

Volltextzugriff (PDF)

Present and future treatment options for primary CNS lymphoma

Expert opinion on pharmacotherapy, 2015-11, Vol.16 (17), p.2569-2579

2015

Volltextzugriff (PDF)

Marginal zone lymphomas and infectious agents

Seminars in cancer biology, 2013-12, Vol.23 (6), p.431-440

2013

Volltextzugriff (PDF)

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

Journal of clinical oncology, 2011-07, Vol.29 (20), p.2766-2772

2011

Volltextzugriff (PDF)

1 – 25 von 356

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(330)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(166)
Humans
(153)
Oncology
(127)
Male
(97)
Female
(94)
Middle Aged
(89)
Aged
(79)
Adult
(74)
Biological And Medical Sciences
(52)
Lymphoma
(52)
Medical Sciences
(51)
Prognosis
(50)
Treatment Outcome
(44)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(39)
Aged, 80 And Over
(38)
Hematologic And Hematopoietic Diseases
(32)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(31)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(30)
Chemotherapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

CNS prophylaxis for diffuse large B-cell lymphoma

Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)

A Reappraisal of the Diagnostic and Therapeutic Management of Uncommon Histologies of Primary Ocular Adnexal Lymphoma

Primary central nervous system lymphoma – Biological aspects and controversies in management

Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial

Primary and secondary bone lymphomas

Breaching the Blood–Brain Tumor Barrier for Tumor Therapy

NGR-TNF Engineering with an N‑Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity

Primary central nervous system lymphoma

Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type

Present and future treatment options for primary CNS lymphoma

Marginal zone lymphomas and infectious agents

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

[18F] Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study

Aktive Filter

Suchergebnisse filtern